Remus Pharmaceuticals Ltd. : Cash Flow Statement
Industry
Phar
BSE Code
Face Value
10.00
Chairman
NSE Code
Market Lot
100
Group
Not Applicable
ISIN No
INE0O5T01011
Book Closure
14/11/2025
You can view Cashflow Statement.
Particulars
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Months
12
12
12
12
12
Source Of Info (AR = Annual Report, PR = Press Release)
AR
AR
AR
AR
AR
FaceValue
10.00
10.00
10.00
10.00
10.00
Net Profit/Loss Before Extraordinary Items And Tax
26.64
22.52
11.41
4.55
1.36
Net CashFlow From Operating Activities
15.59
2.43
5.31
5.04
2.84
Net Cash Used In Investing Activities
-12.42
-20.90
-15.19
-4.55
-3.09
Net Cash Used From Financing Activities
-1.42
39.29
11.77
-0.17
-0.12
Net Inc/Dec In Cash And Cash Equivalents
1.75
20.81
1.89
0.32
-0.37
Cash And Cash Equivalents Begin of Year
1.71
3.04
1.15
0.83
1.20
Cash And Cash Equivalents End Of Year
3.46
23.85
3.04
1.15
0.83
Company Info
Type first few letters
*